Stay updated on Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.

Latest updates to the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page adds a revision tag 'Revision: v3.4.2' and removes a government funding notice that was previously shown. These changes affect only site-wide information and do not alter the study details, eligibility criteria, outcomes, or contacts.SummaryDifference0.5%

- Check21 days agoChange DetectedA funding-lapse notice was added at the top of the page and the revision tag updated to v3.4.1, replacing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedA 'Show glossary' option has been added to the page. QC-related labels were updated (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the revision stamp now shows v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe only observed change is the revision label updated from v3.3.3 to v3.3.4, with no visible updates to study details, eligibility criteria, or other page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedDifference0.2%

- Check92 days agoChange DetectedThe Publications note was updated to say that PubMed publications are automatically filled from PubMed and may not be about the study. The revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib Pre-Standard Therapy in BRCA+ Breast Cancer Clinical Trial page.